Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Danshen Dripping Pills in type 2 diabetes complications
ChiCTR-TRC-12001975Phase 4Completed
- Sponsor
- Shengjing Hospital of China Medical University, and Affiliated Hospital of Liaoning University of Chinese Traditional Medicine
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Compound Danshen in diabetic retinopathy (DR) and diabetic glomerulosclerosis (2 arms), sponsored by Shengjing Hospital of China Medical University, and Affiliated Hospital of Liaoning University of Chinese Traditional Medicine. Primary endpoints: Urine microalbumin/creatinine ratio, Microaneurysms and 3 more. Started Feb 2012; status: completed.
02
Drugs
Compound Danshen
03
Conditions
diabetic retinopathy (DR)diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-12001975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12001975.